Efficacy of nimesulide versus meloxicam in the control of pain, swelling and trismus following extraction of impacted lower third molar.

This study compared the efficacy of nimesulide and meloxicam in the control of pain, swelling and trismus, following the extraction of impacted inferior third molars. Twenty patients with two impacted inferior third molars, in similar positions, were selected. The patients were designated randomly to the meloxicam group (MEL: 7.5mg twice a day for 5 days) or the nimesulide group (NIM: 100mg for 5 days). Following the extractions, swelling was more pronounced in the MEL group than in the NIM group (P<or=0.001). There were no significant differences in pain intensity between the treatment groups (P>0.05). At the 72-h evaluation, reduction was significantly larger in mouth opening in the MEL group compared with the NIM group (P<0.05). In conclusion, pain control was similar in both treatment groups. NIM was more effective than MEL in the control of swelling and trismus following the extraction of impacted lower third molars.

[1]  F. Herrmann,et al.  Pain in Severe Dementia: Self‐Assessment or Observational Scales? , 2006, Journal of the American Geriatrics Society.

[2]  A. Macciocchi,et al.  Controlled Clinical Investigation of Acute Analgesic Activity of Nimesulide in Pain after Oral Surgery , 2012, Drugs.

[3]  P. Moore,et al.  Preemptive rofecoxib and dexamethasone for prevention of pain and trismus following third molar surgery *. , 2005, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[4]  R. Dionne,et al.  Comparison of nonsteroidal anti-inflammatory drugs, ibuprofen and flurbiprofen, with methylprednisolone and placebo for acute pain, swelling, and trismus. , 1990, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[5]  K. Rainsford.  Nimesulide – a multifactorial approach to inflammation and pain: scientific and clinical consensus , 2006, Current medical research and opinion.

[6]  H. Kehlet,et al.  Non-steroidal anti-inflammatory drugs: rationale for use in severe postoperative pain. , 1991, British journal of anaesthesia.

[7]  M. Katori,et al.  Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. , 1997, Pharmacology.

[8]  R. Dionne,et al.  Evaluation of preoperative ibuprofen for postoperative pain after removal of third molars. , 1978, Oral surgery, oral medicine, and oral pathology.

[9]  James P. Pigott.  Principles of Exodontia as Applied to the Impacted Mandibular Third Molar , 1928, The Yale Journal of Biology and Medicine.

[10]  A. Carvajal,et al.  Hepatotoxicity associated with nimesulide: data from the Spanish Pharmacovigilance System. , 2002, Clinical pharmacology and therapeutics.

[11]  R. Seymour,et al.  An investigation into post-operative pain after third molar surgery under local analgesia. , 1985, The British journal of oral & maxillofacial surgery.

[12]  Lipsky Pe.  Role of cyclooxygenase-1 and -2 in health and disease. , 1999 .

[13]  J. Gordon,et al.  Evaluation of dexamethasone for reduction of postsurgical sequelae of third molar removal. , 1992, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[14]  B. Sessle,et al.  Effects of inflammatory irritant application to the rat temporomandibular joint on jaw and neck muscle activity , 1995, Pain.

[15]  A. Pedersen.  Decadronphosphate in the relief of complaints after third molar surgery. A double-blind, controlled trial with bilateral oral surgery. , 1985, International journal of oral surgery.

[16]  H. Precheur.  Peterson's Principles of Oral and Maxillofacial Surgery, Second Edition, Michael Miloro, Peter E. Larsen, G.E. Ghali, Peter D. Waite (Eds.). B. C. Decker, Inc., Hamilton (Canada) and London (UK) (2004), 1502 , 2005 .

[17]  F. Scalvini,et al.  A Controlled Clinical Study of the Efficacy and Tolerability of Nimesulide vs Naproxen in Maxillo-Facial Surgery , 2012, Drugs.

[18]  M. Katori,et al.  Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors , 2000, Inflammation Research.

[19]  G. Engelhardt.  Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. , 1996, British journal of rheumatology.

[20]  P. Tonelli,et al.  A Double-Blind Comparison of Nimesulide and Ketoprofen in Dental Surgery , 2012, Drugs.

[21]  C. Ong,et al.  The analgesic efficacy of intravenous versus oral tramadol for preventing postoperative pain after third molar surgery. , 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[22]  A. S. Trindade,et al.  Analgesic and anti-inflammatory dose-response relationship of 7.5 and 15 mg meloxicam after lower third molar removal: a double-blind, randomized, crossover study. , 2007, International journal of oral and maxillofacial surgery.

[23]  A. Kaneko,et al.  Premedication with cyclooxygenase-2 inhibitor meloxicam reduced postoperative pain in patients after oral surgery. , 2006, International journal of oral and maxillofacial surgery.